Drug Discovery News, Articles, Events

Application Notes supplement 2018
Researchers are always looking more effective and efficient ways of making their work more successful. In this supplement, some of our commercial partners share their data, detailing the application of their technology.
T-cells engineered to recognise tumours expressing the CD30 protein marker
Researchers have genetically engineered immune cells to recognise and fight Hodgkin and non-Hodgkin lymphoma cells...
Hit-to-Lead In-Depth Focus 2018
This In-Depth Focus examines our understanding of the comprehensive and complex innate immune system, to develop novel treatments and an open source model to eliminate nuisance compounds
Screening In-Depth Focus 2018
This In-Depth Focus looks at a high-throughput approach for measuring intracellular ATP levels to access compound-mediated cellular toxicity, the role of drug transporters in phenotypic screening, and how to leverage the power of HTS in the new and rapidly evolving collaborative drug discovery landscape.

#soliloquy-container-17517{opacity:1}#soliloquy-container-17517 li>.soliloquy-caption{display:none}#soliloquy-container-17517 li:first-child>.soliloquy-caption{display:block} Application Notes supplement 2018

T-cells engineered to recognise tumours expressing the CD30 protein marker

Latest news

Prolonging antibiotic potency by differentiating between resilience and resistance

whitepaper

Application note: A novel solution to expedite antibody discovery

Supplement

Application Notes supplement 2018

Event

3D Cell Culture

From our latest issue...

webinar

Compliance with data integrity and computerised system validations

Content Hub

TTP Labtech - Designs and manufactures robust, reliable and easy-to-use solutions

Website development by e-Motive Media Limited.